Eczema control and treatment satisfaction in atopic dermatitis patients treated with dupilumab - a cross-sectional study from the BioDay registry.

Jart Ate Franke OosterhavenLotte S SpekhorstJunfen ZhangAngelique N VoorbergGeertruida L E RomeijnCeleste M BoesjesMarlies de GraafMarjolein de Bruin-Weller Marie-Louise A Schuttelaar

Published in: The Journal of dermatological treatment (2021)

When considering the favorable scores on other PROMs and the TSQM v. II, and comparing these to the relatively low percentage of patients perceiving control according to the ADCT, interpretability of eczema control still appears difficult. Treatment satisfaction in the studied cohort was high.

Keyphrases

atopic dermatitis
patient reported outcomes
end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
risk factors